LEXICON PHARMACEUTICAL

Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology's 71st Annual Scientific Session (ACC.22)

02 4 2022 12:15:00 提供 Nasdaq GlobeNewswire

New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)

21 3 2022 08:01:00 提供 Nasdaq GlobeNewswire

Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin

17 3 2022 16:14:31 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical Update

28 2 2022 06:01:00 提供 Nasdaq GlobeNewswire

Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022

28 2 2022 06:00:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022

25 2 2022 21:03:49 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare Conference

13 1 2022 09:00:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare Conference

04 1 2022 16:05:00 提供 Nasdaq GlobeNewswire

Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

30 12 2021 16:05:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference and the Piper Sandler 33rd Annual Healthcare Conference

15 11 2021 16:30:00 提供 Nasdaq GlobeNewswire

Lexicon’s Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the Full Range of Kidney Function in New Analysis of Clinical Data

14 11 2021 08:35:00 提供 Nasdaq GlobeNewswire

New Analysis to be Presented at the American Heart Association Scientific Sessions 2021 Evaluating Cardiovascular Benefits Across Baseline Kidney Function

09 11 2021 08:00:04 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update

03 11 2021 16:02:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 3, 2021

28 10 2021 19:27:58 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

15 9 2021 08:00:01 提供 Nasdaq GlobeNewswire

Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of Care

30 8 2021 07:00:00 提供 Nasdaq GlobeNewswire

Lexicon’s Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpoints: Results from Soloist and Scored Trials

23 8 2021 06:09:19 提供 Nasdaq GlobeNewswire

Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer

30 7 2021 07:01:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update

30 7 2021 07:00:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021

28 7 2021 17:40:44 提供 Nasdaq GlobeNewswire